Switch theme
Sign up to access all valuation multiples
Medplus Health Services Ltd is a pharmacy retailer. It offers pharmaceutical and wellness products such as medicines, vitamins, medical devices, test kits, and others. The company also offers an omnichannel platform wherein customers can purchase products through stores, place orders over the telephone, online orders, and a Click and Pick facility. Its operating segments include Retail, Diagnostics, and Others.
2006
1.2K+
LTM Revenue $735M
LTM EBITDA $57.1M
$1.2B
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
MedPlus India has a last 12-month revenue of $735M and a last 12-month EBITDA of $57.1M.
In the most recent fiscal year, MedPlus India achieved revenue of $647M and an EBITDA of $45.8M.
MedPlus India expects next 12-month revenue of XXX and NTM EBITDA of XXX
See MedPlus India valuation multiples based on analyst estimates| FY 2023 | FY 2024 | FY 2025 | LTM | NTM | |
|---|---|---|---|---|---|
| Revenue | $526M | $647M | XXX | XXX | XXX |
| Gross Profit | $89.8M | $113M | XXX | XXX | XXX |
| Gross Margin | 17% | 17% | XXX | XXX | XXX |
| EBITDA | $36.3M | $45.8M | XXX | XXX | XXX |
| EBITDA Margin | 7% | 7% | XXX | XXX | XXX |
| Net Profit | $11.1M | $5.8M | XXX | XXX | XXX |
| Net Margin | 2% | 1% | XXX | XXX | XXX |
| Net Debt | $14.1M | n/a | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
As of April 15, 2025, MedPlus India's stock price is INR 790 (or $9).
MedPlus India has current market cap of INR 94.5B (or $1.1B), and EV of INR 102B (or $1.2B).
See MedPlus India trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $1.2B | $1.1B | XXX | XXX | XXX | XXX | $0.14 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Sign UpAs of April 15, 2025, MedPlus India has market cap of $1.1B and EV of $1.2B.
MedPlus India's trades at 1.6x LTM EV/Revenue multiple, and 20.7x LTM EBITDA.
Analysts estimate MedPlus India's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See valuation multiples for MedPlus India and 10K+ public comps| FY 2024 | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|
| EV | $1.2B | XXX | XXX | XXX |
| EV/Revenue | 1.7x | XXX | XXX | XXX |
| EV/EBITDA | 21.9x | XXX | XXX | XXX |
| P/E | 76.7x | XXX | XXX | XXX |
| P/E/Growth | 1.8x | XXX | XXX | XXX |
| EV/FCF | 87.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Sign UpMedPlus India's NTM/LTM revenue growth is 14%
MedPlus India's revenue per employee for the last fiscal year averaged $0.6M, while opex per employee averaged $0.1M for the same period.
Over next 12 months, MedPlus India's ratio of sales and marketing spend to revenue is estimated to be XXX , while its R&D spend to revenue to be XXX .
Analysts estimate MedPlus India's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
See operational valuation multiples for MedPlus India and other 10K+ public comps| FY 2024 | NTM | FY 2025E | FY 2026E | FY 2027E | |
|---|---|---|---|---|---|
| Revenue Growth | 23% | XXX | XXX | XXX | XXX |
| EBITDA Margin | 8% | XXX | XXX | XXX | XXX |
| EBITDA Growth | 26% | XXX | XXX | XXX | XXX |
| Rule of 40 (SaaS-only) | 21% | XXX | XXX | XXX | XXX |
| Revenue per Employee | $0.6M | XXX | XXX | XXX | XXX |
| Opex per Employee | $0.1M | XXX | XXX | XXX | XXX |
| S&M Expenses to Revenue | 2% | XXX | XXX | XXX | XXX |
| G&A Expenses to Revenue | 0% | XXX | XXX | XXX | XXX |
| R&D Expenses to Revenue | n/a | XXX | XXX | XXX | XXX |
| Opex to Revenue | 19% | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Pague Menos | XXX | XXX | XXX | XXX | XXX | XXX |
| Droga Raia | XXX | XXX | XXX | XXX | XXX | XXX |
| Redcare Pharmacy | XXX | XXX | XXX | XXX | XXX | XXX |
| Oriola | XXX | XXX | XXX | XXX | XXX | XXX |
| Alibaba Health | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
MedPlus India acquired XXX companies to date.
Last acquisition by MedPlus India was XXXXXXXX, XXXXX XXXXX XXXXXX . MedPlus India acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 60K+ M&A deals.
Sign Up| When was MedPlus India founded? | MedPlus India was founded in 2006. |
| Where is MedPlus India headquartered? | MedPlus India is headquartered in India. |
| How many employees does MedPlus India have? | As of today, MedPlus India has 1.2K+ employees. |
| Who is the CEO of MedPlus India? | MedPlus India's CEO is Mr. Gangadi Madhukar Reddy. |
| Is MedPlus India publicy listed? | Yes, MedPlus India is a public company listed on BOM. |
| What is the stock symbol of MedPlus India? | MedPlus India trades under 543427 ticker. |
| When did MedPlus India go public? | MedPlus India went public in 2021. |
| Who are competitors of MedPlus India? | Similar companies to MedPlus India include e.g. Pague Menos, Droga Raia, Redcare Pharmacy, Oriola. |
| What is the current market cap of MedPlus India? | MedPlus India's current market cap is $1.1B |
| What is the current revenue of MedPlus India? | MedPlus India's last 12-month revenue is $735M. |
| What is the current EBITDA of MedPlus India? | MedPlus India's last 12-month EBITDA is $57.1M. |
| What is the current EV/Revenue multiple of MedPlus India? | Current revenue multiple of MedPlus India is 1.6x. |
| What is the current EV/EBITDA multiple of MedPlus India? | Current EBITDA multiple of MedPlus India is 20.7x. |
| What is the current revenue growth of MedPlus India? | MedPlus India revenue growth between 2023 and 2024 was 23%. |
| Is MedPlus India profitable? | Yes, MedPlus India is EBITDA-positive (as of the last 12 months). |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.
